BIO-RAD LABORATORIES, INC. — Director's Dealing 2016

Mar 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-03-14

Reporting Person: TSINGOS CHRISTINE A (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-14	Bio-Rad A Common Stock	M	200	$84.57	Acquired	4879.0979	Direct
2016-03-14	Bio-Rad A Common Stock	S	200	$138.65	Disposed	4679.0979	Direct
2016-03-14	Bio-Rad A Common Stock	M	400	$84.57	Acquired	5079.0979	Direct
2016-03-14	Bio-Rad A Common Stock	S	400	$137.64	Disposed	4679.0979	Direct
2016-03-14	Bio-Rad A Common Stock	M	2400	$98.04	Acquired	7079.0979	Direct
2016-03-14	Bio-Rad A Common Stock	S	2400	$137.64	Disposed	4679.0979	Direct
2016-03-14	Bio-Rad A Common Stock	M	400	$119.54	Acquired	5079.0979	Direct
2016-03-14	Bio-Rad A Common Stock	S	400	$137.64	Disposed	4679.0979	Direct
2016-03-14	Bio-Rad A Common Stock	M	1280	$117.00	Acquired	5959.0979	Direct
2016-03-14	Bio-Rad A Common Stock	S	1280	$137.64	Disposed	4679.0979	Direct
2016-03-14	Bio-Rad A Common Stock	M	1950	$107.32	Acquired	6629.0979	Direct
2016-03-14	Bio-Rad A Common Stock	S	1950	$137.64	Disposed	4679.0979	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-14	Non-Qualified Stock Option (right to buy)	$84.57	M	600	Disposed	2020-09-08	Bio-Rad A Common Stock (600)	Direct
2016-03-14	Non-Qualified Stock Option (right to buy)	$98.04	M	2400	Disposed	2021-11-04	Bio-Rad A Common Stock (2400)	Direct
2016-03-14	Non-Qualified Stock Option (right to buy)	$107.32	M	1950	Disposed	2022-09-12	Bio-Rad A Common Stock (1950)	Direct
2016-03-14	Non-Qualified Stock Option (right to buy)	$117.00	M	1280	Disposed	2023-09-11	Bio-Rad A Common Stock (1280)	Direct
2016-03-14	Non-Qualified Stock Option (right to buy)	$119.54	M	400	Disposed	2024-09-10	Bio-Rad A Common Stock (400)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.50 to $138.01, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The option vested in five equal annual installments beginning September 8, 2011.

F3: The option vested in five equal annual installments beginning November 4, 2012.

F4: The option vested in five equal annual installments beginning September 12, 2013

F5: The option vested in five equal annual installments beginning September 11, 2014.

F6: The option vested in five equal annual installments beginning September 10, 2015.